Table 5.
Outcome and overall survival data according to the treatment in 32 intramedullary spinal cord metastases from RCC.
| Treatment | Clinical Outcome | Overall Survival | |||||
|---|---|---|---|---|---|---|---|
| Stable | Improved | Worsened | n.s. | Alive | Dead | n.s. | |
| Surgery alone (11/32) | 4 | 7 | 0 | 0 | 6 (3–65 mo.) (Mean 24 ± 21.5 SD mo.) |
5 (1–23 mo.) (Mean 11 ± 9.6 SD mo.) |
0 |
| Radiotherapy alone (9/32) | 2 | 5 | 0 | 2 | 3 (1–26 mo.) (Mean 11 ± 13.22 SD mo.) |
4 (4–11 mo.) (Mean 6.75 ± 2.98 SD mo.) |
2 |
| Surgery + Radiotherapy (10/32) |
3 | 4 | 1 | 2 | 5 (3–65 mo.) (Mean 17 ± 26.8 SD mo.) |
4 (1–3 mo.) (Mean 2 ± 1 SD mo.) |
1 |
n.s.: not specified, mo.: months.